Patents by Inventor Shirley W. Hunter

Shirley W. Hunter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acid molecules encoding a novel ectoparasite saliva protein
    Patent number: 7629446
    Abstract: The present invention is directed to a novel product and method for isolating ectoparasite saliva proteins, and a novel product and method for detecting and/or treating allergic dermatitis in an animal. The present invention includes a saliva protein collection apparatus capable of collecting ectoparasite saliva proteins substantially free of contaminating material. The present invention also relates to ectoparasite saliva proteins, nucleic acid molecules having sequences that encode such proteins, and antibodies raised against such proteins. The present invention also includes methods to obtain such proteins and to use such proteins to identify animals susceptible to or having allergic dermatitis. The present invention also includes therapeutic compositions comprising such proteins and their use to treat animals susceptible to or having allergic dermatitis.
    Type: Grant
    Filed: December 14, 2006
    Date of Patent: December 8, 2009
    Assignee: Heska Corporation
    Inventors: Shirley W. Hunter, Lynda Wallenfels, Glenn R. Frank
  • Ectoparasite saliva proteins
    Patent number: 7166693
    Abstract: The present invention is directed to a novel product and method for isolating ectoparasite saliva proteins, and a novel product and method for detecting and/or treating allergic dermatitis in an animal. The present invention includes a saliva protein collection apparatus capable of collecting ectoparasite saliva proteins substantially free of contaminating material. The present invention also relates to ectoparasite saliva proteins, nucleic acid molecules having sequences that encode such proteins, and antibodies raised against such proteins. The present invention also includes methods to obtain such proteins and to use such proteins to identify animals susceptible to or having allergic dermatitis. The present invention also includes therapeutic compositions comprising such proteins and their use to treat animals susceptible to or having allergic dermatitis.
    Type: Grant
    Filed: October 14, 2002
    Date of Patent: January 23, 2007
    Assignee: Heska Corporation
    Inventors: Glenn R. Frank, Shirley W. Hunter, Lynda Wallenfels
  • Novel ectoparasite saliva proteins and apparatus to collect such proteins
    Publication number: 20030185755
    Abstract: The present invention is directed to a novel product and method for isolating ectoparasite saliva proteins, and a novel product and method for detecting and/or treating allergic dermatitis in an animal. The present invention includes a saliva protein collection apparatus capable of collecting ectoparasite saliva proteins substantially free of contaminating material. The present invention also relates to ectoparasite saliva proteins, nucleic acid molecules having sequences that encode such proteins, and antibodies raised against such proteins. The present invention also includes methods to obtain such proteins and to use such proteins to identify animals susceptible to or having allergic dermatitis. The present invention also includes therapeutic compositions comprising such proteins and their use to treat animals susceptible to or having allergic dermatitis.
    Type: Application
    Filed: October 14, 2002
    Publication date: October 2, 2003
    Applicant: Heska Corporation.
    Inventors: Glenn R. Frank, Shirley W. Hunter, Lynda Wallenfels
  • Methods of eliciting an antibody response using flea protease proteins and homologs thereof
    Patent number: 6139840
    Abstract: The present invention relates to flea serine protease and aminopeptidase proteins; to flea serine protease and aminopeptidase nucleic acid molecules, including those that encode such proteins; to antibodies raised against such proteins; and to compounds that inhibit flea serine protease and/or aminopeptdiase activities. The present invention also includes methods to obtain such proteins, nucleic acid moelcules, antibodies, and inhibitors. Also included in the present invention are therapeutic compositions comprising such proteins, nucleic acid molecules, antibodies, and/or inhibitors as well as the use of such therapeutic compositions to protect a host animal from flea infestation.
    Type: Grant
    Filed: August 1, 1997
    Date of Patent: October 31, 2000
    Assignee: Heska Corporation
    Inventors: Robert B. Grieve, Keith E. Rushlow, Shirley W. Hunter, Glenn R. Frank, Gary L. Stiegler